El Pasoans Fighting Hunger to adjust operations amid ‘unstable' funding
EL PASO, Texas (KTSM) — El Pasoans Fighting Hunger (EPFH) Food Bank says it remains at crisis levels while funding is unstable and will adjust food distribution operations to a four-day schedule, the non-profit organization said in a press release on Monday, March 17.
The non-profit says it will hold a press conference at 2 p.m. on Monday, March 17, at its headquarters located at 9541 Plaza Circle to discuss the operational changes.
'Despite our best efforts to meet the growing need, post-COVID fundraising has dropped while need remains high, and government food assistance programs are becoming increasingly unstable. The recent news of a $1 billion cut in federal food assistance grants underscores the challenges food banks across the country are experiencing. As one of the most food-insecure regions in the U.S., El Paso is uniquely vulnerable to these shifts,' the non-profit said.
The non-profit says it will be adjusting food distribution operations to a four-day schedule which will be Tuesday through Friday. Partner pantry distributions will be adjusted to align with available resources, the non-profit said.
'El Pasoans Fighting Hunger remains committed to feeding our neighbors in need, but we are in a difficult position,' said Susan Goodell, CEO of EPFH. 'The reality is, with fewer resources, we must make tough decisions to protect core operations even as we navigate this funding crisis. With a limited local food supply, we must be laser-focused on bringing the most nutritious food into El Paso for our most vulnerable neighbors.'
Those who want to help can donate by clicking here: How to help – EPFH or by volunteering. For more information on volunteering, click here: https://elpasoansfightinghunger.org/volunteer.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
FedEx, Nike and Micron are part of Zacks Earnings Preview
Chicago, IL – June 23, 2025 – releases the list of companies likely to issue earnings surprises. This week's list includes FedEx FDX, Nike NKE and Micron MU. The expectation is for Q2 earnings to increase by +5% from the same period last year on +3.9% higher revenues. This will be a material deceleration from the growth trend of recent quarters. In the unlikely event that actual Q2 earnings growth for the S&P 500 index turns out to be +5% as currently expected, this will be the lowest earnings growth pace for the index since the +4.3% growth rate in 2023 Q3. We have been regularly flagging in recent weeks that 2025 Q2 earnings estimates have been steadily coming down. The magnitude of cuts to 2025 Q2 estimates since the start of the period is larger and more widespread than what we have become accustomed to seeing in the post-COVID period. Since the start of April, Q2 estimates have declined for 14 of the 16 Zacks sectors (Aerospace and Utilities are the only sectors whose estimates have gone up), with the biggest cuts to Conglomerates, Autos, Transportation, Energy, Basic Materials, and Construction sectors. Estimates for the Tech and Finance sectors, the largest earnings contributors to the S&P 500 index, accounting for more than 50% of all index earnings, have also been cut since the quarter got underway. But as we have been pointing out recently, the revisions trend for the Tech sector has notably stabilized in recent weeks. We see this same trend at play in annual estimates as well. A likely explanation for this stabilization in the revisions trend is the easing in the tariff uncertainty after the more punitive version of the tariff regime was delayed. Analysts started revising their estimates lower in the immediate aftermath of the early April tariff announcements, but appear to have since concluded that those punitive tariff levels are unlikely to get levied, helping stabilize the revisions trend. In terms of S&P 500 index 'EPS,' these growth rates approximate to $253.84 for 2025 and $286.87 for 2026. The June-quarter reporting cycle will really get going when the big banks come out with their results on July 15th. But we will have officially counted almost two dozen quarterly reports from S&P 500 members by then. All of those reports will be from companies with fiscal quarters ending in May, which we and other research organizations count as part of the June-quarter tally. We have seen such fiscal May-quarter results from 9 S&P 500 members already and are on track to see another 8 index members come out with results this week. The notable companies reporting this week include FedEx,Nike, Micron and others. FedEx shares were down big in response to the March 20th quarterly release when it missed estimates. But the stock has been struggling for the last couple of years, with the onset of uncertainty around international trade adding to muted demand trends in the industrial sector. FedEx has been actively working to reduce its cost base and lower the business's capital intensity. The board's announcement to spin off the LTL business (less-than-truckload business) is part of that repositioning. FedEx is scheduled to report after the market's close on Tuesday, June 24th. The company is expected to earn $5.94 per share on $21.7 billion in revenues, representing year-over-year changes of +9.8% and -1.9%, respectively. Estimates for the period have steadily come down, with the current $5.94 per share estimate down from $5.98 a month back and $6.32 three months ago. FedEx shares have lost roughly a fifth of their value this year, roughly in line with UPS's performance, but materially below the S&P 500 index's +1.2% gain. The stock is down -2.1% over the last three years, while the S&P 500 index has gained +60.3%. Just like FedEx, Nike is another bellwether that has been struggling lately, with the stock down -21.1% this year when the market as a whole is up +1.2%. Expectations for Nike's quarterly release after the market's close on Thursday, June 26th, remain low, with EPS and revenues expected to decline -89.1% and -15.4% from the same period last year, respectively The headwinds facing Nike include perceptions of a stale product line that has been weighing on demand and the resulting inventory build that needs to be rightsized. The inventory overhang is expected to persist for a few more quarters, but the market will eagerly seek incremental information on the reception of new products and updates on the product pipeline. The margin squeeze is primarily a result of clearing stale inventory, but also reflects the new management team's renewed focus on the wholesale business, which had been neglected in recent years. Micron Technology shares have literally been on fire lately, up +46.2% in the year-to-date period, handily outperforming the Zacks Tech sector's +1.5% gain and the S&P 500 index's +1.2% gain. Driving the stock's impressive momentum is Micron's leadership position in the high-bandwidth memory (HBM) space, a mission-critical input for high-performance computing (HPC) and artificial intelligence (AI) applications. The combination of stable demand trends in legacy products like DRAM and continued strength in HBM is expected to result in strong numbers when Micron reports results after the market's close on Wednesday, June 25th. The expectation is that Micron will report $1.57 per share in earnings on $8.81 billion in revenues, representing year-over-year changes of +153.2% and +29.3%, respectively. Estimates for the fiscal May quarter have remained unchanged over the last three months, although they have increased modestly for the August period and for next year as well. As noted earlier, we have already seen fiscal May-quarter results from 9 S&P 500 members, which we count as part of our Q2 tally. Total earnings for these 9 index members that have reported results are up +2.4% from the same period last year on +7.9% revenue gains, with 77.8% of the companies beating EPS estimates and all of them beating revenue estimates. We are not drawing any conclusions from these results, given the small sample size at this stage. But we nevertheless wanted to put these early results in a historical context. For a detailed view of the evolving earnings picture, please check out our weekly Earnings Trends report here >>>> Earnings Estimates Stabilize: A Closer Look Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year. Today you can access their live picks without cost or obligation. See Stocks Free >> Join us on Facebook: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@ provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NIKE, Inc. (NKE) : Free Stock Analysis Report Micron Technology, Inc. (MU) : Free Stock Analysis Report FedEx Corporation (FDX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Forbes
2 hours ago
- Forbes
A Tale Of Two Prices: Retail Versus Investor Value
Thibault Adrien is the CEO and Founder of Lafayette Real Estate, an asset manager specializing in single family rentals and build to rent. When it comes to real estate prices, there are two distinct lenses through which they can be viewed: retail value and investor value. Understanding the difference is critical for investors in today's market where headlines often blur the lines between the two. For example, a recent article from The Wall Street Journal noted that for publicly traded single-family rental REITs, the investor valuation of housing is currently lower than the retail valuation of those properties, drawing the conclusion that investors believe prices will drop. However, I think the piece misses an important distinction in that investor valuation is not a speculative bet on future retail values. While the divergence between the two is fair, its explanation lies elsewhere: Investor valuations and retail prices differ because they are driven by distinct fundamentals and considerations. Since the rise of this asset class since 2008, the cap rates investors, like my own, have been willing to accept have usually implied a lower value than what a household would be willing to pay. A notable exception was a highly unusual period following Covid, during which surging inflation—fueled by fiscal stimulus—coexisted with historically low interest rates. That environment pushed some investors to be very aggressive, but this unsustainable window closed abruptly in the summer of 2022, triggering a swift retreat by some of our peers. Many remain on the sidelines, seemingly waiting for those conditions to return. (Spoiler: I don't think they will.) Investor Value: A Different Perspective Investor value reflects the amount an investor is willing to pay relative to the income the asset is expected to produce (the yield). As an investor in this space myself, my company, Lafayette Real Estate, views retail home prices as a form of downside protection—a foundational layer of intrinsic value—but not a primary driver of our investment thesis. The projected yield analysis relies on the underlying fundamentals such as supply and demand dynamics, population growth, affordability of rents compared to household income, wage growth, expense inflation and interest rate expectations, which shape long-term returns. Taking a view on these big trends, in a specific location, as well as a more subjective view on the risks/quality of the asset itself, allows investors to then take a shot at projecting each revenue and expense line item for the next 10 years and price an asset accordingly. Retail Value: Historical Performance And Current Trends The retail value of an investment property is the price a household pays when buying a dwelling. Prices, from a retail perspective, have historically outperformed inflation, offering investors a reliable store of value. Of course, neither investors nor economists can predict the future, and in the short term, an increase in homes for sale could put downward pressure on prices in a few markets. Yet overall, the U.S. continues to be plagued by a meaningful housing shortage, estimated to be in the millions of homes. The lock-in effect continues to be relevant with 56% of mortgages below 4% and inventory levels, while having risen since 2022, still remain well below pre-pandemic levels. Critics often cite current high prices as unsustainable, but I think the reality is that these values are just a reflection of the market's supply and demand dynamics. When Investors And Retail Buyers Co-Exist In The Same Market Everybody knows that when yields go up, asset prices go down, right? That might be true for treasuries, but for homes? Forget it. In summer 2022, interest rates rose, supply dropped and home prices went up. In real estate, supply and demand still rule. Investors aren't driving prices—they're reacting to them. Institutional investors (owning 1,000-plus homes) make up just 1% of transactions. But they do offer support: When prices dip, yields rise and investors step in. This helps cushion the market, making a 2008-style crash less likely. Builders know this and value their ties with SFR investors, especially when retail demand cools. Still, investors provide pricing support: If prices go down, yields go up—and investors step in. This dynamic makes a global financial crisis-style scenario, where home prices plummet, which is hard to envision today. Homebuilders also understand this dynamic and work to maintain strong relationships with real estate investors, whom they see as valuable partners when the retail market softens. Where We Stand Today As Investors The fundamentals of rental housing remain compelling, particularly in markets with strong demographic growth and persistent housing shortages. While we are seeing elevated deliveries in some areas, the structural shortage continues—and the recent, significant decline in new rental starts (with multifamily starts down 27% and build-to-rent starts down 60% year-over-year in 2024, according to a John Burns Real Estate Consulting report) will only deepen it. We are confident that projects launched now in dynamic markets will be delivered into favorable supply-demand conditions over the coming years. Disciplined institutional investors don't fixate on the short-term fluctuations of retail home prices or volatile tariff announcements. Instead, they focus on the long-term fundamentals that drive occupancy and portfolio performance. By focusing on well-located properties with strong demand and sound rental economics, you can build a portfolio designed to perform across market cycles, regardless of where retail prices happen to stand, so long as you stay in control of your development and operating costs and deliver an excellent resident experience. Investing in new build-to-rent communities of homes doesn't just capitalize on these trends—it also contributes to the solution. Addressing the housing shortage also means building quality rental options in markets where many households have been priced out or are unwilling to take on the burdens of homeownership. In any case, we have got millions of homes to build to fix the housing crisis, and our mission should be to become part of the solution. So let's get to work, one home at a time. Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Yahoo
3 hours ago
- Yahoo
The 5 Most Interesting Analyst Questions From Pfizer's Q1 Earnings Call
Pfizer's first quarter results drew a positive market response as management emphasized margin improvement and disciplined expense control, even as revenue declined. CEO Albert Bourla credited robust execution in key therapeutic areas, particularly oncology and internal medicine, for helping offset lower sales from COVID-related products. CFO Dave Denton highlighted the impact of productivity programs and a refined commercial approach, noting that adjusted operating expenses fell meaningfully due to ongoing cost realignment. Management acknowledged external pressures, including U.S. policy changes and lower COVID demand, but pointed to operational efficiency as a key factor supporting profitability. Is now the time to buy PFE? Find out in our full research report (it's free). Revenue: $13.72 billion vs analyst estimates of $13.94 billion (7.8% year-on-year decline, 1.6% miss) Adjusted EPS: $0.92 vs analyst estimates of $0.67 (36.5% beat) The company reconfirmed its revenue guidance for the full year of $62.5 billion at the midpoint Management reiterated its full-year Adjusted EPS guidance of $2.90 at the midpoint Market Capitalization: $136.3 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Vamil Divan (Guggenheim): Asked about Pfizer's ability to maintain and grow its dividend amid tariff uncertainty and cash flow pressure. CFO Dave Denton reiterated the dividend's priority in capital allocation and expressed confidence in cost management supporting this commitment. Evan Seigerman (BMO Capital Markets): Inquired about Pfizer's obesity pipeline strategy after discontinuing a candidate. Chief Scientific Officer Chris Boshoff explained the focus on differentiated, more tolerable oral therapies and the pursuit of both internal and external opportunities. Tim Anderson (Bank of America): Questioned the likelihood and scope of sector-specific tariffs and potential impacts on manufacturing. CEO Albert Bourla shared insights from government discussions, highlighting distinctions between friendly and adversary countries and Pfizer's contingency planning. Trung Huynh (UBS): Sought clarity on the timing and magnitude of cost savings. Denton said most additional identified savings would be realized post-2025, with R&D productivity improvements expected to be reinvested in the pipeline. Geoff Meacham (Citi): Asked about business development priorities and the impact of LOEs. Bourla and Chief Strategy Officer Andrew Baum emphasized the focus on building sustainable franchises through both internal R&D and disciplined acquisitions. In the months ahead, the StockStory team will be watching (1) progress on late-stage clinical trial readouts and regulatory decisions in oncology and vaccines, (2) the impact of cost-saving initiatives on operating margins as Pfizer approaches upcoming patent expirations, and (3) developments in global trade policy and tariffs that could affect supply chain resilience. Execution on business development and timely new product launches will also be important markers for future performance. Pfizer currently trades at $24, up from $23.03 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
